Skip to content

PDL BIOPHARMA, INC.

Delisted

CIK 882104fmd_1KAV0HNHK1PX2A6K9T6GTDHTCQManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2008 to Dec 31, 2020, 48 periods

Latest annual · FY2019

Millions
Total revenues
31
Gross profit
13
Operating income
(51)
Net income
(70)
Free cash flow
(28)

Latest quarter · Q2 FY2020

Millions
Total revenues
5
Gross profit
3
Operating income
(14)
Net income
(50)
Free cash flow
(19)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2016 to FY2019
-49.9%
Revenue, 5 yearsFY2014 to FY2019
-44.5%
Net income, 5 yearsFY2014 to FY2019
n/m

PDL BIOPHARMA, INC. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2019FY2018ChangeSource
Revenue$30.7 million$32 million-4.1%8-K 2020-06-29 · proof
Gross profit$13.4 million$18.5 million-27.3%8-K 2020-06-29 · proof
Operating income-$51.1 million-$34.2 million10-K 2021-03-29 · proof
Net income-$70.4 million-$68.9 million10-K 2020-03-11 · proof
Cash from operating activities-$27.7 million-$6.4 million10-K 2021-03-29 · proof
Free cash flow-$28.4 million-$7.5 million10-K 2021-03-29 · proof
Total assets$717.2 million$965.5 million-25.7%10-Q 2020-05-11 · proof
Total liabilities$123.9 million$235.7 million-47.4%10-Q 2020-05-11 · proof
Cash and cash equivalents$169 million$365.7 million-53.8%10-Q 2020-05-11 · proof
What was PDL BIOPHARMA, INC.'s revenue in fiscal 2019?
PDL BIOPHARMA, INC. reported revenue of $30.7 million for fiscal 2019 (the year ended Dec 31, 2019), against $32 million the year before (-4.1%). Source: the 8-K filed with the SEC on Jun 29, 2020 (restated). SEC
What was PDL BIOPHARMA, INC.'s gross profit in fiscal 2019?
PDL BIOPHARMA, INC. reported gross profit of $13.4 million for fiscal 2019 (the year ended Dec 31, 2019), against $18.5 million the year before (-27.3%). Source: the 8-K filed with the SEC on Jun 29, 2020 (restated). SEC
What was PDL BIOPHARMA, INC.'s operating income in fiscal 2019?
PDL BIOPHARMA, INC. reported operating income of -$51.1 million for fiscal 2019 (the year ended Dec 31, 2019), against -$34.2 million the year before. Source: the 10-K filed with the SEC on Mar 29, 2021 (restated). SEC
What was PDL BIOPHARMA, INC.'s net income in fiscal 2019?
PDL BIOPHARMA, INC. reported net income of -$70.4 million for fiscal 2019 (the year ended Dec 31, 2019), against -$68.9 million the year before. Source: the 10-K filed with the SEC on Mar 11, 2020. SEC
What was PDL BIOPHARMA, INC.'s cash from operating activities in fiscal 2019?
PDL BIOPHARMA, INC. reported cash from operating activities of -$27.7 million for fiscal 2019 (the year ended Dec 31, 2019), against -$6.4 million the year before. Source: the 10-K filed with the SEC on Mar 29, 2021 (restated). SEC
What was PDL BIOPHARMA, INC.'s free cash flow in fiscal 2019?
PDL BIOPHARMA, INC. reported free cash flow of -$28.4 million for fiscal 2019 (the year ended Dec 31, 2019), against -$7.5 million the year before. Source: the 10-K filed with the SEC on Mar 29, 2021 (restated). SEC
What are PDL BIOPHARMA, INC.'s total assets?
As of Dec 31, 2019, PDL BIOPHARMA, INC. reported total assets of $717.2 million, against $965.5 million a year earlier (-25.7%). Source: the 10-Q filed with the SEC on May 11, 2020 (restated). SEC
What are PDL BIOPHARMA, INC.'s total liabilities?
As of Dec 31, 2019, PDL BIOPHARMA, INC. reported total liabilities of $123.9 million, against $235.7 million a year earlier (-47.4%). Source: the 10-Q filed with the SEC on May 11, 2020 (restated). SEC
What are PDL BIOPHARMA, INC.'s cash and cash equivalents?
As of Dec 31, 2019, PDL BIOPHARMA, INC. reported cash and cash equivalents of $169 million, against $365.7 million a year earlier (-53.8%). Source: the 10-Q filed with the SEC on May 11, 2020 (restated). SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:882104&period_type=annual&limit=5"

Information only, not investment advice.